host: we have one last call for our guests, joseph in willow springs, north carolina. hey, joseph.s?ph, are you with guest,houghts from our antonio regalado. what are you looking for next in this story and where it is headed? guest: i think the next step is to really dig into the cost. people are trying to model what some of the treatments will cost and reach the market. i mentioned one gene therapy that cost $4 million. a lot of people are working on that question, the economics of that. tackle aresue i will just the prices there are some promising gene therapies out there. muscular dystrophy is a pretty common disease. it is fatal. if it were cured with gene therapy, i think society would then struggle with the true cost. if it ends up costing $2 million, $3 million, it will add up. host: antonio regalado is the biomedicine senior editor at m.i.t. "technology review." thank you for your time this morning. appreciate it. guest: thank you very host: one half hour left in this edition of "washington journal." coming up, we will talk with sarah brown from the chronicle of higher educ